HYFT (MindWalk Holdings Corp.) Stock Market Reviews

crown

search

Read and share opinions on HYFT (MindWalk Holdings Corp.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

HYFT

MindWalk Holdings Corp.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

MindWalk CTO Dr. Dirk Van Hyfte to Join Fireside Chat at AI Drug Discovery & Development Summit 2025
Nov 13, 2025
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy
Oct 21, 2025
MindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial Expansion
Oct 15, 2025
MindWalk Announces Share Repurchase Program
Oct 9, 2025
MindWalk Holdings Corp. (HYFT) Surges with 45% Revenue Growth and Strategic AI-Focused Rebrand
Sep 23, 2025
MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity
Sep 22, 2025
MindWalk Holdings Corp (HYFT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic ...
Sep 16, 2025
MindWalk Holdings Corp. (HYFT) Reports Q1 Loss, Misses Revenue Estimates
Sep 15, 2025
MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet
Sep 15, 2025
MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025
Sep 10, 2025

Reviews